Global Burden of Disease Long COVID Collaborators, Sarah Wulf Hanson, Cristiana Abbafati, Joachim G.J.V. Aerts et al.
Importance: Some individuals experience persistent symptoms after initial symptomatic SARS-CoV-2 infection (often referred to as Long COVID). Objective: To estimate the proportion of males and females with COVID-19, younger or older than 20 years of age, who had Long COVID symptoms in 2020 and 2021 ...
Sarah Wulf Hanson, Cristiana Abbafati, Joachim G.J.V. Aerts, Ziyad Al‐Aly et al.
Importance: While much of the attention on the COVID-19 pandemic was directed at the daily counts of cases and those with serious disease overwhelming health services, increasingly, reports have appeared of people who experience debilitating symptoms after the initial infection. This is popularly kn...
Tjeerd van der Veer, Johanna Margaretha de Koning Gans, Gert‐Jan Braunstahl, Angelina Pieters et al.
<h3>Tweetable abstract</h3> <b>The FORZA trial investigated beclomethasone–formoterol <i>versus</i> placebo in bronchiectasis without asthma or COPD. There were no signs of benefit and more adverse events, which warrants caution for the prescription of ICS/LABA therapy in bronchiectasis.</b>https://...